Safety Incidents OSHA Severe Injury Reports · 2015–2025
2,276,768Injury reports 135,424Establishments Most recent incident 2025-12-31

OSHA Injury Report: Amphastar Pharmaceuticals

Injury · Days away from work

On , an injury at Amphastar Pharmaceuticals in AMPHASTAR PHARMACEUTICALS / 11570 6th Street / Rancho Cucamonga, AMPHASTAR PHARMACEUTICALS / 11570 6th Street / Rancho Cucamonga, CA 91730 resulted in days away from work. Employee was machine OP in medicinal chemicals, uncompounded, manufacturing.

Watch Amphastar Pharmaceuticals for free Get an email when a new federal OSHA severe-injury report for Amphastar Pharmaceuticals is published. One employer, no account, unsubscribe in one click.
Parent company
Amphastar Pharmaceutical Inc.
Street
AMPHASTAR PHARMACEUTICALS / 11570 6th Street / Rancho Cucamonga
City
AMPHASTAR PHARMACEUTICALS / 11570 6th Street / Rancho Cucamonga
State
CA
ZIP
91730
On-site location
Parking Lot
Outcome
Days away from work (code 2)
Type
Injury (code 1)
Days away from work
2

Employee was getting out of his own car.

Employee was walking away from his own car.

Contusion of his right left knees.

No employee fell do his health conditions osteoarthritis.

Contusion of Right and left knees do Osteoarthritis.

Job description
Machine OP
SOC code
51-9199: Production Workers, All Other
NAICS code
325411: Medicinal chemicals, uncompounded, manufacturing
NAICS vintage
2022
Employees at this establishment (2023 average)
652
Hours worked at this establishment (2023 total)
1,096,017
EIN
330702205
Establishment ID
1029552
Employer case #
1
Date of incident
Shift started
05:00
Time of incident
04:45
Filing year
2023
Submitted to OSHA
2024-03-01

View Amphastar Pharmaceuticals's full OSHA safety record →

Data from OSHA ITA Form 300/301 electronic submissions, filing year 2023. ITA Case Detail records are establishment-reported submissions, not OSHA inspections, so no per-record IMIS deep link exists.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.